BCL2 and myocardial ischemia: The activation of ADORA2A promotes cell survival by inhibiting apoptosis and autophagy, thereby mitigating myocardial ischemia–reperfusion injury (MIRI), which may be associated with its capacity to activate the cAMP-PKA pathway and the Beclin-1-Bcl-2 complex [27].